Latest Breaking News On - Aribio co ltd - Page 1 : comparemela.com

AriBio Co., Ltd.: AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)

AriBio Co., Ltd.: AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Czech-republic
Germany
United-kingdom
United-states
Amsterdam
Noord-holland
Netherlands
Italy
South-korea
Denmark
France
Spain

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Netherlands
Italy
United-states
France
Amsterdam
Noord-holland
South-korea
Czech-republic
United-kingdom
Denmark
Germany
Spain

AriBio Licenses Exclusive Marketing Rights for AR1001 for Alzheimer's Disease in China for $770 Million USD

AriBio Licenses Exclusive Marketing Rights for AR1001 for Alzheimer's Disease in China for $770 Million USD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
South-korea
United-kingdom
China
America
Jun-choung
Fred-kim
European-union
Aribio-co-ltd
Samjin-pharmaceutical
Jai-jun
Middle-east